Cambiar Aggressive Value ETF (CAMX)

NYSEARCA: CAMX · Real-Time Price · USD
26.72
-0.43 (-1.60%)
Apr 8, 2025, 1:01 PM EDT - Market closed
-1.60%
Assets $53.05M
Expense Ratio 0.59%
PE Ratio 15.16
Shares Out 1.95M
Dividend (ttm) $0.39
Dividend Yield 1.43%
Ex-Dividend Date Dec 30, 2024
Payout Ratio 21.68%
1-Year Return -6.50%
Volume 277
Open 27.26
Previous Close 27.16
Day's Range 26.72 - 27.26
52-Week Low 26.45
52-Week High 31.71
Beta 0.79
Holdings 29
Inception Date Feb 13, 2023

About CAMX

Fund Home Page

The Cambiar Aggressive Value ETF (CAMX) is an exchange-traded fund that mostly invests in total market equity. The fund is an actively managed, global equity fund. Stock selection and weighting is based on the Issuers strongest belief for long-term capital appreciation. CAMX was launched on Feb 13, 2023 and is issued by Cambiar Funds.

Asset Class Equity
Category Global Large-Stock Value
Region Global
Stock Exchange NYSEARCA
Ticker Symbol CAMX
ETF Provider Cambiar Funds

Top 10 Holdings

46.43% of assets
Name Symbol Weight
Elevance Health, Inc. ELV 6.95%
Uber Technologies, Inc. UBER 5.84%
Energy Transfer LP ET 4.83%
Delta Air Lines, Inc. DAL 4.73%
Bristol-Myers Squibb Company BMY 4.48%
Labcorp Holdings Inc. LH 4.45%
Cenovus Energy Inc. CVE 4.03%
Nintendo Co., Ltd. NTDOY 3.95%
CME Group Inc. CME 3.66%
Centene Corporation CNC 3.52%
View More Holdings

Dividends

Ex-Dividend Amount Pay Date
Dec 30, 2024 $0.3884 Jan 7, 2025
Dec 28, 2023 $0.1464 Jan 5, 2024
Full Dividend History

News

Camurus announces positive Phase 3 results from the ACROINNOVA 2 study of octreotide SC depot (CAM2029) in acromegaly patients

Treatment well tolerated with a safety profile consistent with standard-of-care (SoC) Increased biochemical response rates (IGF-1 ≤ 1xULN) vs SoC at baseline Continuous improvement of acromegaly sympt...

9 months ago - PRNewsWire

Cambiar Investors Launches Aggressive Value ETF

DENVER--(BUSINESS WIRE)--Cambiar Investors announces the launch of a new active ETF.

2 years ago - Business Wire